Revenue and profitability:
- Revenue: Not disclosed / not reported in QQ1 2024 data.
- Gross profit: Not reported.
- Operating income: -€221.50 (YoY: 16.39% improvement versus prior period reported figure, QoQ: 4.60% improvement). Note: The data shows a negative operating income across QQ1 2024.
- Net income: -€220.67 (YoY: -/+ 16.41% depending on prior period base; QoQ: -3.93%).
- EBITDA: -€221,281.50 (significantly negative); Depreciation and amortization: €221.50. The magnitude gap between EBITDA and D&A implies potential data reconciliation anomalies in the supplied figures.
- EPS (diluted): -€0.00000673 per share; Weighted average diluted shares: 32,800,820.
Liquidity, leverage and cash flow:
- Current ratio: 0.613; Quick ratio: 0.613; Cash ratio: 0.148.
- Cash and cash equivalents: €91,003 (balance sheet reported figure).
- Net debt: -€91,003 (negative debt position on the balance sheet, implying net cash).
- CFO (operating cash flow): -€272k; Free cash flow: -€272k.
- Cash flow from financing: €383k; Net change in cash: -€2k; Cash at end of period: -€2k (note: end-period cash figure appears inconsistent with cash and equivalents on the balance sheet; data units may be EUR thousands).
Balance sheet and capitalization:
- Total assets: €10,041,768k (approx €10.04m).
- Total current assets: €376,798k; Total non-current assets: €9,664,970k.
- Intangible assets: €9,047,352k; Goodwill: none; Long-term investments: €541,262k.
- Total liabilities: €614,384k; Total stockholders’ equity: €9,427,384k.
- Share count: 33,435,150 weighted average shares outstanding; 32,800,820 diluted.
- Price-to-book: 0.355; Enterprise value to forward measures are negative due to the negative earnings multiple context.
- Holdings quality indicators: Significant intangible assets and long-term investments underpin the balance sheet, while cash generation from operations remains negative in QQ1 2024.